Aptus Capital Advisors’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
VPM
VCM
Aptus Capital Advisors's EXEL Position: Q1 2026 in Review
Aptus Capital Advisors reduced its Exelixis (EXEL) stake by 6% in Q1 2026, selling an estimated $16.5K and leaving 5,950 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #930.
Aptus Capital Advisors first reported a position in EXEL in Q4 2025 and has held it in 2 quarters since. The position peaked at $278K in Q4 2025. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.
- Aptus Capital Advisors held 5,950 shares of Exelixis worth $255K as of Q1 2026.
- Aptus Capital Advisors sold 383 Exelixis shares in Q1 2026, an estimated $16.5K.
- Exelixis made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q1 2026, its #930 holding.
- Aptus Capital Advisors first reported a position in Exelixis in Q4 2025 and has held it in 2 quarters since.
- Aptus Capital Advisors's Exelixis position peaked at $278K in Q4 2025.
- 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.
Based on Aptus Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.